a disease that can be communicated from one person to another
- non-communicable disease threats, such as those related to chemical and environmental issues, requiring rapid intervention;
- non-communicable disease threats such as those related to chemical and environmental issues requiring rapid intervention;
- communicable disease management aspects of migrant health and cross-border issues;
- Other priorities are: non-communicable disease threats, such as those related to chemical and environmental issues, requiring rapid intervention;
- communicable disease management aspects of migrant health and cross-border issues, including screening and contact tracing issues;
- Other priorities are: non-communicable disease threats such as those related to chemical and environmental issues requiring rapid intervention;
- Health security and strategies relevant to communicable disease control (Article 3.2.a., Annex — points 2.2, 2.4, 2.5, 2.9)
- According to the European Communicable Disease Bulletin, Eurosurveillance, of January 1999, which is a special issue on botulism in Europe, botulism is very rare in Denmark.
- According to the World Health Organisation (WHO) European Health report 2005, in terms of Disability Adjusted Life-Years (DALYs), the most important causes of the burden of disease in the WHO European Region are non-communicable diseases (NCDs — 77 % of the total), external causes of injury and poisoning (14 %) and communicable diseases (9 %).
- For the communicable diseases and special health issues listed in this Annex, epidemiological surveillance within the Community network is to be performed by the standardised collection and analysis of data in a way that is to be determined for each communicable disease and special health issue when specific surveillance networks are put in place.
- Developing strategies and mechanisms for preventing, exchanging information on and responding to non-communicable disease threats, including gender-specific health threats and rare diseases (Article 3.2.d., Annex — point 2.3)
- In addition, the placing on the market, including the importation, of such animal by-products should only be allowed if they originate from animals that do not show clinical signs of any disease communicable through colostrum to humans or animals.
- Responsibility for the analysis and assessment of communicable diseases falls under the remit of the European Centre for Disease Control (ECDC)  and actions developed to support the management of these risks have been developed in consultation with the ECDC.
- Strengthening the role of the European Centre for Disease Prevention and Control established by Regulation (EC) No 851/2004 of the European Parliament and of the Council  is important in the fight against communicable diseases.
- Manifestation of a disease or an occurrence that creates a potential for a disease pursuant to Article 1 of the International Health Regulations (2005) which is a communicable disease pursuant to Annex to Decision No 2119/98/EC and related measures to be notified to the World Health Organization under Article 6 of the International Health Regulations (2005).’